Brexit panic is good news for bargain hunters

Professional investor William Meadon picks three of his favourite UK stocks.

A professional investor tells us where he'd put his money. This week: William Meadon of the JP Morgan Claverhouse Investment Trust picks three favourites.

There is a great deal of uncertainty surrounding the British economy and stockmarket. But despite all the doom and gloom, the economy is in better shape than many realise. Indeed, in stark contrast to the horror stories and negative headlines, what we're seeing on the ground, at the company level, are a number of bright spots. It's easy to miss these opportunities if you don't tune out the Brexit-related noise.

JPMorgan Claverhouse aims to provide both capital and income growth for its shareholders by investing in a portfolio of 60 to 80 quoted British equities: reasonably valued quality companies with improving prospects. The fund has just announced its 46th consecutive annual dividend increase, the longest of any UK-only investment trust quoted on the London Stock Exchange.

The housing gloom has gone too far

What's more, the Help-to-Buy programme is making house purchases more accessible and, if the scheme finishes as planned in 2023, there should be an increasing number of people taking advantage of it in the coming years. We particularly like Barratt Developments (LSE:BDEV) thanks to its strategy of focusing on areas outside London, where there is less concentrated Brexit risk and, consequently, lower house-price volatility. Barratt's management are experienced, astute operators and although the 8% dividend yield on the shares includes some special payments, even in the absence of these the shares looks attractive.

New managers will boost Glaxo

GlaxoSmithKline (LSE:GSK)

However, a change in management should gradually improve the reputation of the company. In the meantime, investors are being paid generously to wait through the quarterly payment of a dividend currently worth more than 5% of the share price. Furthermore, the recent joint venture with Pfizer's consumer health business highlights the strategic choices available to the company and the management's ability to exploit them.

A top record in infrastructure

John Laing Group (LSE: JLG)

Recommended

Beyond US tech stocks: three global stars to buy now
Share tips

Beyond US tech stocks: three global stars to buy now

There is much to like about the US tech giants, says professional investor Alec Cutler of Orbis Investments highlights. But there are many other excel…
1 May 2021
Share tips of the week
Share tips

Share tips of the week

MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
19 Feb 2021
How to prepare your business for Brexit
Small business

How to prepare your business for Brexit

Whether we have a Brexit deal or not, new procedures for importers and exporters will apply from 1 January. Get your business ready now.
27 Nov 2020
Micro-cap stocks: how to get huge returns from tiny firms
Small cap stocks

Micro-cap stocks: how to get huge returns from tiny firms

Micro-cap stocks are often overlooked, but the British market has plenty of them and their potential is massive. Max King picks the best two investmen…
3 May 2021

Most Popular

What is hyperinflation and could it happen here?
Inflation

What is hyperinflation and could it happen here?

The Bank of England has been accused of the kind of money-printing that could lead to Zimbabwe-style hyperinflation. But that's very unlikely to happe…
4 May 2021
Copper has hit a ten-year high, but this could just be the start of a huge bull market
Industrial metals

Copper has hit a ten-year high, but this could just be the start of a huge bull market

The price of copper is at its highest for ten years. But supply constraints and a massive rise in demand mean it’s not going to stop there, says Domin…
5 May 2021
Micro-cap stocks: how to get huge returns from tiny firms
Small cap stocks

Micro-cap stocks: how to get huge returns from tiny firms

Micro-cap stocks are often overlooked, but the British market has plenty of them and their potential is massive. Max King picks the best two investmen…
3 May 2021